1,3-butadiene has been researched along with Abdominal Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dybing, E; Kroese, D; Roelfzema, H; Sanner, T; Tennant, RW | 1 |
1 other study(ies) available for 1,3-butadiene and Abdominal Neoplasms
| Article | Year |
|---|---|
T25: a simplified carcinogenic potency index: description of the system and study of correlations between carcinogenic potency and species/site specificity and mutagenicity.
Topics: Abdominal Neoplasms; Adenocarcinoma, Bronchiolo-Alveolar; Animals; Butadienes; Carcinogenicity Tests; Carcinogens; Carcinoma, Hepatocellular; Carcinoma, Transitional Cell; Chloroform; Female; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Mesothelioma; Mice; Mutagenesis; Neoplasms, Experimental; Rats; Rats, Inbred F344; Species Specificity; Toluidines; Urinary Bladder Neoplasms | 1997 |